Efficacy and safety of semaglutide 2.4 mg once-weekly in adults with overweight or obesity and type 2 diabetes (STEP 2)
Stress management deserves mention here because stress directly increases stomach acid production and heightens esophageal sensitivity
We specialize in supplying high-purity research peptides with a focus on transparency, fast domestic delivery, and dedicated customer support
Across these trials, semaglutide consistently led to significant reductions in body weight, averaging 14.9% in STEP 1, 9.6% in STEP 2 (patients with type 2 diabetes), and 16% in STEP 3 (with intensive behavioral therapy)
Even more importantly, her blood work showed an across-the-board improvement in metabolic health markers including cholesterol, triglycerides, and blood sugar levels